Literature DB >> 3013025

Alpha 1-adrenergic constriction limits coronary flow and cardiac function in running dogs.

P A Gwirtz, S P Overn, H J Mass, C E Jones.   

Abstract

Modulation of coronary blood flow and cardiac function by alpha 1-adrenergic receptors was examined in dogs during strenuous exercise. Fifteen dogs were chronically instrumented to measure left circumflex blood flow, heart rate, regional left ventricular function (systolic shortening, and rate of shortening), and global left ventricular function (left ventricular pressure, and dP/dt). The specific postsynaptic alpha 1-receptor blocker prazosin (0.5 mg) and nonselective alpha-receptor blocker phentolamine (1.0 mg) were injected through an indwelling circumflex artery catheter to produce local adrenergic blockade of the posterior left ventricular region during exercise. Exercise significantly increased heart rate, left ventricular systolic pressure, dP/dt, segment shortening and rate of shortening, and coronary blood flow. Both prazosin and phentolamine caused similar additional increases in dP/dt by 21 +/- 4%, in rate of shortening in the posterior region by 37 +/- 6%, and in myocardial O2 consumption by 26 +/- 11%, which were associated with a 21 +/- 3% increase in coronary flow during exercise but no change in O2 extraction. Similar results were obtained when dogs were beta-blocked with either atenolol (1.0 mg ic) or propranolol (1.0 mg ic) prior to exercise. These data suggest that an alpha 1-vasoconstriction modulates O2 delivery to myocardial tissue and limits both coronary vasodilation and cardiac function during exercise.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013025     DOI: 10.1152/ajpheart.1986.250.6.H1117

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Muscle metaboreflex-induced coronary vasoconstriction functionally limits increases in ventricular contractility.

Authors:  Matthew Coutsos; Javier A Sala-Mercado; Masashi Ichinose; Zhenhua Li; Elizabeth J Dawe; Donal S O'Leary
Journal:  J Appl Physiol (1985)       Date:  2010-04-22

2.  Minimal alpha 1- and alpha 2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine.

Authors:  R Schulz; R J Oudiz; B D Guth; G Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

3.  Importance of alpha 1-sympathetic activity for diurnal change in ischemic threshold in patients with stable angina.

Authors:  M Fujita; T Tanaka; I Nakae; S Tamaki; Y Kihara; R Nohara; S Sasayama
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

Review 4.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 5.  No adrenergic constriction in isolated coronary arterioles?

Authors:  E O Feigl
Journal:  Basic Res Cardiol       Date:  1995 Jan-Feb       Impact factor: 17.165

Review 6.  alpha-adrenergic responses of isolated canine coronary microvessels.

Authors:  C J Jones; L Kuo; M J Davis; W M Chilian
Journal:  Basic Res Cardiol       Date:  1995 Jan-Feb       Impact factor: 17.165

Review 7.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

8.  Alpha 1-adrenergic blockade reduces exercise-induced regional myocardial ischemia in dogs.

Authors:  B D Guth; T Miura; E Thaulow; G Heusch; J Ross
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

9.  Cardiac mechanics are impaired during fatiguing exercise and cold pressor test in healthy older adults.

Authors:  Matthew D Muller; Jessica L Mast; Hardikkumar Patel; Lawrence I Sinoway
Journal:  J Appl Physiol (1985)       Date:  2012-11-15

10.  Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failure.

Authors:  Matthew Coutsos; Javier A Sala-Mercado; Masashi Ichinose; Zhenhua Li; Elizabeth J Dawe; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.